Faculty

Institution

Unit

Venue

Dr. Thomas A. Dix, Ph.D.

Medical University of South Carolina

Affiliations

College of Pharmacy

NoneDr. Thomas A. Dix, Ph.d. is currently serving as a College Of Pharmacy faculty at Medical University of South Carolina.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Dr. Thomas A. Dix, Ph.D.

Medical University of South Carolina

You can click a keyword to filter the displayed items

pharmacology neuroscience biochemistry medicinal chemistry neuropharmacology medicinal research peptide science receptors peptides neurology therapeutic targets bioorganic chemistry neuropeptides pharmaceutical chemistry stroke drug discovery chemical biology respiratory medicine protein science receptor (biochemistry) opioid use disorder natural product synthesis asymmetric synthesis neuropsychopharmacology enzyme inhibition pharmacotherapy pain research peptide therapeutics pain therapy peptide engineering pharmacological hypothermia animal physiology mammalian biology future medicinal chemistry drug analysis pharmacological research thrombosis vascular biology opioid overdose neurochemistry neuropeptide receptors functional selectivity pain mechanism traumatic brain injury severe stroke peripheral pain clinical neuroscience neuroinflammation cerebrovascular disease pharmaceutical research pharmaceutical sciences opioid epidemic psychoactive drugs psychopharmacology experimental pharmacology neuromodulation (medicine) adverse events vascular pharmacology cohort studies vascular access brain circulation protein mass spectrometry radiation exposure analytical biotechnology spectrochemical analysis inflammatory cytokines ischemic stroke therapeutic hypothermia microglia polarization focal cerebral ischemia novel stroke therapy neonatal rats therapeutic effects therapeutic potential kappa opioid agonists antipsychotic potential

Notable Scholarly Works

Notable Federal Grants

Collaborators

Biased Opioid Receptor Ligands: Gain Without Pain. Trends in Endocrinology and Metabolism (2020)

Tyler C. BeckThomas A. DixRussell A. Norris

metabolismpain researchreceptor (biochemistry)opioid receptor ligandspharmacologytherapeutic targetstherapeutic efficacyopioid use disorderendocrinologypain medicinereceptorspain managementpain mechanism

The C-C Chemokine Receptor Type 4 is an Immunomodulatory Target of Hydroxychloroquine. Frontiers in Pharmacology (2020)

Tyler C. BeckKyle R. BeckCalvin B. HollowayRichard A. HemingsThomas A. DixRussell A. Norris

immunologyimmunomodulatory targetimmunomodulationimmune responsespharmacologypharmacological researchreceptors

Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist. Medical Sciences (2019)

Tyler C. BeckMatthew A. HapstackGautam S. GhatnekarThomas A. Dix

substance use disordersneurologyinhibitory activityapplied pharmacologymedicinal researchneurosciencediuretic activityneuropathologyaddictionpharmacologytherapeutic targetsopioid overdoseopioid use disorderpharmacotherapypain medicinereceptorssystem pharmacologyanesthetic pharmacology

Non-Addictive Orally-Active Kappa Opioid Agonists for the Treatment of Peripheral Pain in Rats. European Journal of Pharmacology (2019)

Tyler C. BeckCarmela M. ReichelKristi L. HelkeSanat S. BhadsavleThomas A. Dix

pharmacologyperipheral painpharmacological researchopioid use disorderpain management

Pharmacological Hypothermia Induced Neurovascular Protection After Severe Stroke of Transient Middle Cerebral Artery Occlusion in Mice. Experimental Neurology (2019)

Yingying ZhaoZheng Zachory WeiJin Hwan LeeXiaohuan GuJinmei SunThomas A. DixLing WeiShan P. Yu

cardiovascular diseaseimmunologyneuromuscular medicineemergency medicineadverse eventscirculatory physiologyphysiologyconcussioncerebral blood flowsevere strokeneurosurgerypharmacological hypothermianeurovascular protectionthrombosisstrokecardiovascular researchcohort studiesvascular pharmacologybrain circulationvascular accesscentral nervous system

Targeting Peripheral Kappa Opioid Receptors for the Treatment of Chronic Pain: Review Article.. PubMed (2019)

Tyler C BeckThomas A DixCarmela M Reichel

pain researchanti-inflammatoryneuropathic painopioid use disordersymptom managementanesthesiologyneurosciencepharmacologynervous systemtherapeutic targetschronic painpain therapypain medicinereceptorspain managementpain mechanismreview article

Targeting Peripheral κ-Opioid Receptors for the Non-Addictive Treatment of Pain. Future Drug Discovery (2019)

Tyler C BeckThomas A Dix

non-addictive treatmentpharmacologypain therapydrug discoveryperipheral k-opioid receptorspain management

Therapeutic Potential of Kappa Opioid Agonists. Pharmaceuticals (2019)

Tyler C. BeckMatthew A. HapstackKyle R. BeckThomas A. Dix

kappa opioid agonistsopioid epidemicpharmaceutical sciencesmedicinal researchtherapeutic potentialpharmacologytherapeutic targetsopioid overdoseopioid use disorderpharmaceutical research

The Effects of Pharmacological Hypothermia Induced by Neurotensin Receptor Agonist Abs 201 on Outcomes of Cpr. Shock (2018)

Hao LiTianfeng HuaWei WangXiaobo WuChangqing MiaoWeiping HuangYan XiaoJin YangJennifer L. BradleyMary Ann PeberdyJoseph OrnatoThomas A. DixTyler BeckWanchun Tang

respiratory medicinepharmacologypharmacological hypothermiaemergency medicineneurotensin receptor agonist

Longitudinal Mri Evaluation of Neuroprotective Effects of Pharmacologically Induced Hypothermia in Experimental Ischemic Stroke. Magnetic Resonance Imaging (2017)

Silun WangXiaohuan GuRamesh PaudyalLing WeiThomas A. DixShan P. YuXiaodong Zhang

neuropharmacologyneuroscienceneuroradiologypharmacologylongitudinal mri evaluationneuroprotective effectsneuroprotectionexperimental ischemic strokemedical imagingrespiratory medicinemagnetic resonance imagingclinical evidenceneuroimagingstrokeneurologybrain imagingcognitive neurosciencebrain sciencemagnetic resonancemammalian biology

1
2
3
4
10 / page

Dr. Thomas A. Dix, Ph.D.

Medical University of South Carolina

Affiliations

College of Pharmacy

NoneDr. Thomas A. Dix, Ph.d. is currently serving as a College Of Pharmacy faculty at Medical University of South Carolina.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Dr. Thomas A. Dix, Ph.D.

Medical University of South Carolina

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Biased Opioid Receptor Ligands: Gain Without Pain. Trends in Endocrinology and Metabolism (2020)

Tyler C. BeckThomas A. DixRussell A. Norris

The C-C Chemokine Receptor Type 4 is an Immunomodulatory Target of Hydroxychloroquine. Frontiers in Pharmacology (2020)

Tyler C. BeckKyle R. BeckCalvin B. HollowayRichard A. HemingsThomas A. DixRussell A. Norris

immunologyimmunomodulatory targetimmunomodulationimmune responsespharmacologypharmacological researchreceptors

Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist. Medical Sciences (2019)

Tyler C. BeckMatthew A. HapstackGautam S. GhatnekarThomas A. Dix

Non-Addictive Orally-Active Kappa Opioid Agonists for the Treatment of Peripheral Pain in Rats. European Journal of Pharmacology (2019)

Tyler C. BeckCarmela M. ReichelKristi L. HelkeSanat S. BhadsavleThomas A. Dix

pharmacologyperipheral painpharmacological researchopioid use disorderpain management

Pharmacological Hypothermia Induced Neurovascular Protection After Severe Stroke of Transient Middle Cerebral Artery Occlusion in Mice. Experimental Neurology (2019)

Yingying ZhaoZheng Zachory WeiJin Hwan LeeXiaohuan GuJinmei SunThomas A. DixLing WeiShan P. Yu

Targeting Peripheral Kappa Opioid Receptors for the Treatment of Chronic Pain: Review Article.. PubMed (2019)

Tyler C BeckThomas A DixCarmela M Reichel

Targeting Peripheral κ-Opioid Receptors for the Non-Addictive Treatment of Pain. Future Drug Discovery (2019)

Tyler C BeckThomas A Dix

non-addictive treatmentpharmacologypain therapydrug discoveryperipheral k-opioid receptorspain management

Therapeutic Potential of Kappa Opioid Agonists. Pharmaceuticals (2019)

Tyler C. BeckMatthew A. HapstackKyle R. BeckThomas A. Dix

kappa opioid agonistsopioid epidemicpharmaceutical sciencesmedicinal researchtherapeutic potentialpharmacologytherapeutic targetsopioid overdoseopioid use disorderpharmaceutical research

The Effects of Pharmacological Hypothermia Induced by Neurotensin Receptor Agonist Abs 201 on Outcomes of Cpr. Shock (2018)

Hao LiTianfeng HuaWei WangXiaobo WuChangqing MiaoWeiping HuangYan XiaoJin YangJennifer L. BradleyMary Ann PeberdyJoseph OrnatoThomas A. DixTyler BeckWanchun Tang

respiratory medicinepharmacologypharmacological hypothermiaemergency medicineneurotensin receptor agonist

Longitudinal Mri Evaluation of Neuroprotective Effects of Pharmacologically Induced Hypothermia in Experimental Ischemic Stroke. Magnetic Resonance Imaging (2017)

Silun WangXiaohuan GuRamesh PaudyalLing WeiThomas A. DixShan P. YuXiaodong Zhang

1
2
3
4
10 / page

Similar Faculty Members

Carrie Haskell-Luevano

Institution

University of Minnesota

voluntary exercise

peptide

Val J. Watts

Institution

Purdue University

pharmacology

neuroscience

Corey Hopkins

Institution

University of Nebraska Medical Center

future medicinal chemistry

mechanisms of action

Robin Polt

Institution

University of Arizona

lipid chemistry

biomolecular engineering

Gunda I. Georg

Institution

University of Minnesota

future medicinal chemistry

medicinal chemistry

Philip Portoghese

Institution

University of Minnesota

opioid receptors

pharmacology

Yan Zhang

Institution

Virginia Commonwealth University

psychoactive substance use

world psychiatry

Courtney Aldrich

Institution

University of Minnesota

medicinal chemistry

pharmacology

Henry Mosberg

Institution

University of Michigan

medicine

pharmaceutical science

John Traynor

Institution

University of Michigan

pharmacology

neuroscience

Similar Faculty Members

Carrie Haskell-Luevano

Institution

University of Minnesota

voluntary exercise

peptide

Val J. Watts

Institution

Purdue University

pharmacology

neuroscience

Corey Hopkins

Institution

University of Nebraska Medical Center

future medicinal chemistry

mechanisms of action

Robin Polt

Institution

University of Arizona

lipid chemistry

biomolecular engineering

Gunda I. Georg

Institution

University of Minnesota

future medicinal chemistry

medicinal chemistry

Philip Portoghese

Institution

University of Minnesota

opioid receptors

pharmacology

Yan Zhang

Institution

Virginia Commonwealth University

psychoactive substance use

world psychiatry

Courtney Aldrich

Institution

University of Minnesota

medicinal chemistry

pharmacology

Henry Mosberg

Institution

University of Michigan

medicine

pharmaceutical science

John Traynor

Institution

University of Michigan

pharmacology

neuroscience